142 related articles for article (PubMed ID: 2939068)
1. Influence of glycosylation on allelic and cell-specific Mr variation, receptor processing, and ligand binding of the human complement C3b/C4b receptor.
Lublin DM; Griffith RC; Atkinson JP
J Biol Chem; 1986 May; 261(13):5736-44. PubMed ID: 2939068
[TBL] [Abstract][Full Text] [Related]
2. Human complement C3b/C4b receptor (CR1) mRNA polymorphism that correlates with the CR1 allelic molecular weight polymorphism.
Holers VM; Chaplin DD; Leykam JF; Gruner BA; Kumar V; Atkinson JP
Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2459-63. PubMed ID: 3031685
[TBL] [Abstract][Full Text] [Related]
3. The identification of N-linked oligosaccharides on the human CR2/Epstein-Barr virus receptor and their function in receptor metabolism, plasma membrane expression, and ligand binding.
Weis JJ; Fearon DT
J Biol Chem; 1985 Nov; 260(25):13824-30. PubMed ID: 4055758
[TBL] [Abstract][Full Text] [Related]
4. Polymorphism of the C3b/C4b receptor (CR1): characterization of a fourth allele.
Dykman TR; Hatch JA; Aqua MS; Atkinson JP
J Immunol; 1985 Mar; 134(3):1787-9. PubMed ID: 3155774
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the human glomerular C3 receptor as the C3b/C4b complement type one (CR1) receptor.
Fischer E; Appay MD; Cook J; Kazatchkine MD
J Immunol; 1986 Feb; 136(4):1373-7. PubMed ID: 2418113
[TBL] [Abstract][Full Text] [Related]
6. Analysis of C3b/C4b receptor (CR1) polymorphic variants by tryptic peptide mapping.
Nickells MW; Seya T; Holers VM; Atkinson JP
Mol Immunol; 1986 Jun; 23(6):661-8. PubMed ID: 2943987
[TBL] [Abstract][Full Text] [Related]
7. Biosynthesis of the human C3b/C4b receptor during differentiation of the HL-60 cell line. Identification and characterization of a precursor molecule.
Atkinson JP; Jones EA
J Clin Invest; 1984 Nov; 74(5):1649-57. PubMed ID: 6334100
[TBL] [Abstract][Full Text] [Related]
8. Biosynthesis and glycosylation of the human complement regulatory protein decay-accelerating factor.
Lublin DM; Krsek-Staples J; Pangburn MK; Atkinson JP
J Immunol; 1986 Sep; 137(5):1629-35. PubMed ID: 2427577
[TBL] [Abstract][Full Text] [Related]
9. Identification of an additional class of C3-binding membrane proteins of human peripheral blood leukocytes and cell lines.
Cole JL; Housley GA; Dykman TR; MacDermott RP; Atkinson JP
Proc Natl Acad Sci U S A; 1985 Feb; 82(3):859-63. PubMed ID: 3871945
[TBL] [Abstract][Full Text] [Related]
10. Control of the function of substrate-bound C4b-C3b by the complement receptor Cr1.
Medof ME; Nussenzweig V
J Exp Med; 1984 Jun; 159(6):1669-85. PubMed ID: 6233387
[TBL] [Abstract][Full Text] [Related]
11. Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis.
Klickstein LB; Bartow TJ; Miletic V; Rabson LD; Smith JA; Fearon DT
J Exp Med; 1988 Nov; 168(5):1699-717. PubMed ID: 2972794
[TBL] [Abstract][Full Text] [Related]
12. Structural and functional studies on the human C3b/C4b receptor (CR1) purified by affinity chromatography using a monoclonal antibody.
Holers VM; Seya T; Brown E; O'Shea JJ; Atkinson JP
Complement; 1986; 3(2):63-78. PubMed ID: 2945695
[TBL] [Abstract][Full Text] [Related]
13. Identification of a partial cDNA clone for the C3d/Epstein-Barr virus receptor of human B lymphocytes: homology with the receptor for fragments C3b and C4b of the third and fourth components of complement.
Weis JJ; Fearon DT; Klickstein LB; Wong WW; Richards SA; de Bruyn Kops A; Smith JA; Weis JH
Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5639-43. PubMed ID: 3016712
[TBL] [Abstract][Full Text] [Related]
14. Proposed structure of the F' allotype of human CR1. Loss of a C3b binding site may be associated with altered function.
Wong WW; Farrell SA
J Immunol; 1991 Jan; 146(2):656-62. PubMed ID: 1670949
[TBL] [Abstract][Full Text] [Related]
15. Human C3b/C4b receptor (CR1). Demonstration of long homologous repeating domains that are composed of the short consensus repeats characteristics of C3/C4 binding proteins.
Klickstein LB; Wong WW; Smith JA; Weis JH; Wilson JG; Fearon DT
J Exp Med; 1987 Apr; 165(4):1095-112. PubMed ID: 2951479
[TBL] [Abstract][Full Text] [Related]
16. Quantitative variations of the C3b/C4b receptor (CR1) in human erythrocytes are controlled by genes within the regulator of complement activation (RCA) gene cluster.
Rodriguez de Cordoba S; Rubinstein P
J Exp Med; 1986 Oct; 164(4):1274-83. PubMed ID: 2944984
[TBL] [Abstract][Full Text] [Related]
17. Regulation of proteolytic activity of complement factor I by pH: C3b/C4b receptor (CR1) and membrane cofactor protein (MCP) have different pH optima for factor I-mediated cleavage of C3b.
Seya T; Okada M; Nishino H; Atkinson JP
J Biochem; 1990 Feb; 107(2):310-5. PubMed ID: 2141838
[TBL] [Abstract][Full Text] [Related]
18. Translation of the human C3b/C4b receptor mRNA in a cell-free system and by Xenopus oocytes.
Kumar V; Farries T; Swierkoz J; Atkinson JP
Biochemistry; 1989 May; 28(9):4040-6. PubMed ID: 2665812
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies to mouse complement receptor type 1 (CR1). Their use in a distribution study showing that mouse erythrocytes and platelets are CR1-negative.
Kinoshita T; Takeda J; Hong K; Kozono H; Sakai H; Inoue K
J Immunol; 1988 May; 140(9):3066-72. PubMed ID: 2966205
[TBL] [Abstract][Full Text] [Related]
20. Identification of the C3b receptor-binding domain in third component of complement.
Becherer JD; Lambris JD
J Biol Chem; 1988 Oct; 263(28):14586-91. PubMed ID: 2971659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
